Maintaining the structure of protein and peptide drugs has become one of the most important
goals of scientists in recent decades. Cold and thermal denaturation conditions …

Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent an unmet
clinical need whose prognosis is still dismal. Alterations of immune response play a …

In spite of consistent progress at the level of basic research and of clinical treatment, acute
myeloid leukemia (AML) still represents an unmet clinical need for adult and pediatric …

Mixed-phenotype acute leukemia (MPAL) comprises a heterogenous group of leukemias
that are genetically, immunophenotypically, and clinically, diverse. Given the rarity of the …

Leukaemia is the common name for a group of malignant diseases of the haematopoietic
system with complex classifications and characteristics. Remarkable progress has been …

Simple Summary Cancers can grow and spread to different parts of the body. The aim of
immunotherapy is to stimulate the immune system to eliminate cancer cells in a selective …

The prognosis of patients with acute myeloid leukemia (AML) is limited, especially for elderly
or unfit patients not eligible for hematopoietic stem cell (HSC) transplantation. The disease is …

Acute myeloid leukemia (AML) is a clonal malignant disorder of myeloid progenitor cells
characterized by uncontrolled proliferation, dysregulation in the differentiation program, and …

Acute myeloid leukemia (AML) is the most common acute leukemia in the adult population. It
is characterized by the high proliferation of undifferentiated hematopoietic cells, which …

The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T
Cell–Mediated Killing of AML Leukemic Stem Ce Page 1 source: https://doi.org/10.48350/196383 …